Advertisement


Patricia A. Ganz, MD, on Progress in Cancer Survivorship Care

2018 Cancer Survivorship Symposium: Advancing Care and Research

Advertisement

Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her 30-year-long career researching and advocating for survivors and quality care.



Related Videos

Survivorship

Lawrence N. Shulman, MD, on The New Survivorship Standard: Expert Perspective

Lawrence N. Shulman, MD, of Abramson Cancer Center at the University of Pennsylvania, discusses the Commission on Cancer’s efforts to promote robust survivorship care and how its new recommendations will affect clinical practice and patients.

Breast Cancer
Survivorship

Electra D. Paskett, PhD, on Breast Cancer and Arm Mobility: Clinical Trial Results

Electra D. Paskett, PhD, of The Ohio State University Comprehensive Cancer Center, discusses study findings on whether exercise helps women with breast cancer regain arm mobility after lymph node surgery (Abstract 123).

Colorectal Cancer
Survivorship
Symptom Management

David Baraghoshi, on Colorectal Cancer and Cardiovascular Disease Risk

David Baraghoshi, of the Huntsman Cancer Institute at the University of Utah, discusses an assessment of cardiovascular risk more than 10 years after diagnosis for colorectal cancer survivors compared with a cancer-free general population cohort (Abstract 113).

Survivorship

Christopher J. Recklitis, PhD, MPH, on Mental Health in Cancer Survivors

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, summarizes two key papers on mental health: suicide risk among survivors of head and neck cancer vs other types of cancer; and the fear of cancer recurrence—its associations with mental health status and individual characteristics among cancer survivors (Abstract 146).

Survivorship
Lymphoma

Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).

Advertisement

Advertisement




Advertisement